Krishna Institute of Medical Sciences
add_icon

Krishna Institute of Medical Sciences

720.60
+16.10
(2.29%)
Market Cap
28,834.01 Cr
PE Ratio
89.42
Volume
2,82,833.00
Day High - Low
735.00 - 690.00
52W High-Low
798.40 - 501.55
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
28,834.01 Cr
EPS
9.61
PE Ratio
89.42
PB Ratio
12.40
Book Value
56.74
EBITDA
814.80
Dividend Yield
0.00 %
Sector
Hospitals
Return on Equity
17.15
Debt to Equity
0.99
Analyst Rating and Forecast
- By Refinitiv from13 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+84.62 %
+84.62 %
Hold
Hold+7.69 %
+7.69 %
Sell
Sell+7.69 %
+7.69 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Krishna Institute of Medical Sciences schedules board meeting to consider fund raising through QIP and/or rights issue, with shareholders' approval to be sought for the proposal.
positive
Krishna Institute of Medical Sciences posted consolidated revenue of Rs 9,977 million in Q3FY26, up from Rs 7,724 million in Q3FY25. The company approved additional investment of up to Rs 100 crores in subsidiary Sarvejana Healthcare.
positive
Krishna Institute of Medical Sciences shareholders approved material related party transaction with subsidiary KIMS Hospital Bengaluru through postal ballot with 93.18% votes in favor.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
7,724.50
#1 1,11,066.46
59.92
#1 21,994.30
14.76
#1 1,505
36.08
62.84
1,042.00
1,01,362.57
72.54
7,184.10
#1 28.65
1,076
26.01
45.23
892.55
67,383.79
70.89
7,849.70
13.25
809
-22.38
45.70
1,755.30
35,871.45
46.38
5,575.00
12.29
790
-34.33
42.18
672.70
34,854.00
94.61
4,286.70
15.12
337
-8.85
71.15
1,110.10
29,838.42
58.12
3,771.40
12.59
481
-33.52
43.64
720.60
#7 28,834.01
#9 89.42
#7 3,067.00
#3 21.98
#6 415
#10 -43.89
60.07
443.25
14,027.53
88.46
1,757.00
27.64
110
#1 54.61
43.06
1,199.40
12,181.01
47.18
1,566.90
17.46
244
7.26
48.64
5,289.00
11,728.31
#1 24.23
599.90
11.69
58
12.46
48.75
Growth Rate
Revenue Growth
21.98 %
Net Income Growth
23.49 %
Cash Flow Change
11.65 %
ROE
6.85 %
ROCE
-11.21 %
EBITDA Margin (Avg.)
2.27 %

Quarterly Financial Results

Quarterly Financials
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
268
206
411
361
363
478
417
398
388
501
588
569
581
609
655
609
638
693
782
790
812
879
965
1,003
Expenses
203
165
268
268
258
330
283
264
259
358
412
411
413
449
475
459
475
509
559
585
599
679
757
799
EBITDA
65
40
143
93
105
148
134
134
129
143
177
158
168
160
180
150
163
184
223
205
213
200
208
204
Operating Profit %
24 %
18 %
34 %
26 %
28 %
30 %
31 %
33 %
31 %
28 %
27 %
27 %
28 %
26 %
27 %
24 %
25 %
26 %
28 %
24 %
25 %
22 %
21 %
20 %
Depreciation
17
17
16
20
17
17
18
19
19
29
31
33
35
32
33
35
46
39
41
45
53
53
66
79
Interest
10
9
7
9
7
6
3
3
4
6
8
12
5
9
9
12
16
18
20
26
27
33
45
57
Profit Before Tax
38
14
120
65
81
125
113
112
107
107
138
113
127
119
139
102
100
127
162
135
134
114
97
69
Tax
10
5
29
17
22
33
29
28
24
28
31
31
29
32
37
26
29
32
42
42
28
29
25
17
Net Profit
28
9
90
48
59
92
84
84
83
79
106
82
99
87
101
77
72
95
121
93
106
85
72
52
EPS in ₹
3.72
1.49
11.21
6.55
7.72
11.48
10.34
10.14
10.08
8.74
12.14
9.49
11.65
10.10
11.50
8.98
8.18
10.82
2.68
2.22
2.54
1.96
1.67
1.33

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
958
1,118
1,196
1,436
1,907
2,941
3,852
5,736
Fixed Assets
755
863
916
931
1,005
1,766
2,434
3,349
Current Assets
156
174
220
451
393
478
547
697
Capital Work in Progress
0
0
2
9
21
477
600
1,214
Investments
0
0
0
0
333
68
157
99
Other Assets
203
254
278
496
549
630
660
1,075
Total Equity & Liabilities
958
1,118
1,196
1,436
1,907
2,941
3,852
5,736
Current Liabilities
749
201
219
278
215
297
452
836
Non Current Liabilities
347
351
366
282
282
707
1,307
2,481
Total Equity
-138
566
611
876
1,411
1,938
2,093
2,419
Reserve & Surplus
-209
466
523
786
1,307
1,590
1,748
2,058
Share Capital
50
75
75
78
80
80
80
80

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
5
-11
5
3
-3
33
12
-27
36
-15
9
Investing Activities
-71
-41
-100
-64
-110
-125
-354
-412
-416
-753
-1,116
Operating Activities
64
95
82
106
134
202
356
324
432
521
582
Financing Activities
12
-66
24
-39
-27
-44
10
61
20
217
543

Share Holding

% Holding
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
38.84 %
38.84 %
38.84 %
38.84 %
38.84 %
38.84 %
38.84 %
38.84 %
38.84 %
38.84 %
38.82 %
38.82 %
38.82 %
38.82 %
38.82 %
38.82 %
34.11 %
34.11 %
34.11 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
8.61 %
8.61 %
0.00 %
14.25 %
0.00 %
16.73 %
17.84 %
15.85 %
15.68 %
15.45 %
15.54 %
15.03 %
14.33 %
DIIs
13.81 %
16.11 %
18.35 %
18.49 %
20.46 %
27.98 %
28.32 %
29.76 %
33.03 %
34.80 %
31.63 %
33.13 %
32.12 %
32.30 %
32.05 %
31.95 %
31.66 %
32.12 %
32.71 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
13.14 %
14.23 %
13.38 %
12.88 %
11.81 %
11.50 %
11.32 %
11.10 %
11.22 %
11.15 %
10.84 %
10.73 %
10.61 %
10.55 %
10.97 %
11.24 %
11.58 %
11.72 %
11.76 %
Others
34.21 %
30.82 %
29.42 %
29.79 %
28.88 %
21.68 %
12.92 %
11.69 %
16.91 %
0.96 %
18.70 %
0.59 %
0.61 %
2.48 %
2.48 %
2.54 %
7.11 %
7.03 %
7.09 %
No of Share Holders
0
267
86,389
74,355
73,664
70,795
67,735
60,980
65,449
66,957
71,014
69,092
69,063
77,617
95,468
1,01,895
1,08,955
1,04,872
1,01,599

Announcements

Board Meeting Intimation for Prior Intimation Of Board Meeting To Be Held On 11Th March 2026.4 hrs ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 20, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 16, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 13, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 09, 2026
General UpdateFeb 07, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 07, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 06, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 06, 2026
Announcement under Regulation 30 (LODR)-AcquisitionFeb 06, 2026
Q3FY26Feb 06, 2026
Board Meeting Outcome for Outcome Of Board MeetingFeb 06, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 05, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 04, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportFeb 03, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 02, 2026
Board Meeting Intimation for The Unaudited (Standalone & Consolidated) Financial Results Of The Company For The 03Rd Quarter And Nine-Months Ended December 31 2025.Feb 02, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 09, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 03, 2026
Shareholder Meeting / Postal Ballot-Notice of Postal BallotJan 02, 2026
Receipt Of Demand Order From GST Department By SPANV MEDISEARCH LIFESCIENCES PRIVATE LIMITED (Subsidiary Company).Jan 01, 2026
Closure of Trading WindowDec 26, 2025
Krishna Institute Of Medical Sciences Limited (The Company) Has Entered Into A Leave And License Agreement With Andhra Mahila Sabha For Taking Land Admeasuring Approximately 1.168 Acres (Equivalent To 21.19 Grounds) Located At Dr. Durgabai Deshmukh Road RDec 21, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionDec 19, 2025
Commencement Of Operations At PES University Campus In Electronic City BengaluruDec 15, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 14, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 14, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 11, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 10, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 08, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 07, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 07, 2025
Krishna Institute Of Medical Sciences Limited Has Informed The Exchange Regarding Limited Review Reports On Standalone & Consolidated Financials For The Quarter And Half Year Ended September 30 2025Nov 07, 2025
Announcement under Regulation 30 (LODR)-AcquisitionNov 07, 2025
Results For The Quarter And Half Year Ended 30.09.2025Nov 07, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On 07Th November 2025Nov 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 04, 2025
Announcement U/R 30 Of LODROct 29, 2025
Board Meeting Intimation for The Unaudited (Standalone & Consolidated) Financial Results Of The Company For The 02Nd Quarter And Half-Year Ended September 30 2025.Oct 24, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 14, 2025
Closure of Trading WindowSep 25, 2025
Commencement Of Operations At KIMS Hospital Mahadevapura BengaluruSep 15, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 09, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 08, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 01, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMAug 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 26, 2025
It Has Come To Attention That The Annexure Containing Additional Information Of The Director Seeking Re-Appointment As Required Under Regulation 36(3) Of The SEBI (LODR) Regulations 2015 And Secretarial Standard On General Meetings (SS-2) Issued By The InAug 21, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Axis Services Opportunities Fund Direct - Growth
0.00%
-755292
-2.64%
-2.47%
Invesco India Consumption Fund Direct - Growth
0.00%
-284915
-3.29%
-3.11%
SBI Long Term Advantage Fund Series VI Direct - Growth
0.00%
-109500
-2.53%
-2.46%
Bandhan Healthcare Fund Direct - Growth
0.00%
-80000
-1.73%
-1.54%
JioBlackRock Nifty Smallcap 250 Index Fund Direct - Growth
0.00%
-30803
-0.78%
-0.75%
Groww Small Cap Fund Direct-Growth
0.00%
-6342
-0.23%
0.00%
WhiteOak Capital Equity Savings Fund Direct - Growth
0.00%
-3616
-0.10%
-0.10%
DSP Nifty Smallcap 250 Index Fund Direct - Growth
0.00%
-1091
-0.78%
-0.74%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.00%
-687
-0.07%
-0.07%
Navi Nifty MidSmallcap 400 Index Fund Direct - Growth
0.00%
-496
-0.26%
-0.26%
DSP Nifty 500 Index Fund Direct-Growth
0.00%
-149
-0.08%
0.00%
Mirae Asset Aggressive Hybrid Fund Direct-Growth
0.00%
0
0.00%
-0.42%
Bandhan Multi Asset Allocation Fund Direct-Growth
0.00%
0
0.00%
0.00%
Axis Value Fund Direct-Growth
0.00%
0
0.00%
-0.29%
Bajaj Finserv Small Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Mirae Asset Small Cap Fund Direct-Growth
0.00%
0
0.00%
-1.72%
Axis Nifty 500 Index Fund Direct-Growth
0.00%
0
0.00%
-0.08%
Bandhan Midcap Fund Direct-Growth
0.00%
0
0.00%
-0.97%
Mirae Asset Nifty Total Market Index Fund Direct-Growth
0.00%
0
0.00%
-0.07%
Bandhan Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
0
0.00%
-0.79%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.00%
0
0.00%
-0.07%
Bandhan Small Cap Fund Direct-Growth
0.00%
0
0.00%
-0.14%
Bank of India Small Cap Fund Direct-Growth
0.00%
0
0.00%
-1.21%
Capitalmind Flexi Cap Fund Direct - Growth
0.00%
0
0.00%
0.00%
Axis Multicap Fund Direct-Growth
0.00%
0
0.00%
-0.39%

Technical Indicators

RSI(14)
Neutral
56.12
ATR(14)
Less Volatile
24.90
STOCH(9,6)
Neutral
58.23
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
-0.71
ADX(14)
Strong Trend
33.05
UO(9)
Bearish
52.98
ROC(12)
Uptrend And Accelerating
2.94
WillR(14)
Neutral
-60.68

About Krishna Institute of Medical Sciences

Krishna Institute of Medical Sciences Limited (KIMS) is an Indian healthcare company operating 12 multispecialty hospitals under the KIMS Hospitals brand. With over 4,000 beds, KIMS provides tertiary and quaternary healthcare services across more than 40 specialties and super specialties. The company's network includes hospitals in Telangana, Andhra Pradesh, and...more
Listing Date
28 Jun, 2021(4 Years, 6 days)
Chairperson NameBhaskara Rao Bollineni